18 November 2026 ASX ANNOUNCEMENT Interim CEO Remuneration Update Medical Developments International (ASX: MVP) refers to its announcement dated 15 October 2026 and the appointment of Anita James as Interim Chief Executive Officer in addition to her role as Chief Financial Officer. MVP today...
Interim CEO Remuneration Update
Filed with ASX · · 1 page · English
Summary by 6ix AI
Medical Developments International Limited has announced an update regarding the remuneration of its Interim CEO, Anita James, who also serves as Chief Financial Officer. The revised remuneration arrangements include an increase in total fixed remuneration while maintaining existing incentive percentages. The notice period for termination has been extended from three months to six months. Additionally, retention payments have been scheduled for the following year.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Medical Developments International Limited on 6ix
Earlier from Medical Developments International
- Change in substantial holding
- 2026 Annual General Meeting Recording
- Results of 2026 Annual General Meeting
- 2026 Annual General Meeting Presentation
- 2026 Annual General Meeting Chair and CEO Address
Later from Medical Developments International
All Medical Developments International news releasesFollow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International